Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.
Identifieur interne : 000028 ( PubMed/Corpus ); précédent : 000027; suivant : 000029Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.
Auteurs : Jian Zhuo ; Hai-Bin Wei ; Fei Zhang ; Hai-Tao Liu ; Fu-Jun Zhao ; Bang-Min Han ; Xiao-Wen Sun ; Shu-Jie XiaSource :
- Asian journal of andrology [ 1745-7262 ] ; 2016.
Abstract
The 2-μm thulium laser resection of the prostate-tangerine technique (TmLRP-TT) has been introduced as a minimally invasive treatment for benign prostatic hyperplasia (BPH). This study was undertaken to assess the clinical efficacy and safety of TmLRP-TT for the treatment of BPH patients with previously negative transrectal prostate biopsy. A prospective analysis of 51 patients with previously negative transrectal prostate biopsy who underwent surgical treatment using TmLRP-TT was performed from December 2011 to December 2013. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at 1 and 6 months. TmLRP-TT was successfully completed in all patients. Mean prostate volume, operative duration, and catheterization time were 93.3 ± 37.9 ml, 69.5 ± 39.5 min, and 6.5 ± 1.3 days, respectively. The mean International Prostate Symptom Score, quality of life score, maximum urinary flow rate, and post-void residual urine volume changed notably at 6-month follow-up (22.5 ± 6.9 vs 6.1 ± 3.2, 4.8 ± 1.3 vs 1.1 ± 0.9, 7.3 ± 4.5 vs 18.9 ± 7.1 ml s-1 , and 148.7 ± 168.7 vs 28.4 ± 17.9 ml). Two (3.9%) patients required blood transfusion perioperatively, while 3 (5.9%) patients experienced transient hematuria postoperatively, and 2 (3.9%) patients received 3 days recatheterization due to clot retention. TmLRP-TT is a safe and effective minimally invasive technique for patients with previously negative transrectal prostate biopsy during the 6-month follow-up. This promising technology may be a feasible surgical method for previously negative transrectal prostate biopsy in the future.
PubMed: 26732107
Links to Exploration step
pubmed:26732107Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.</title><author><name sortKey="Zhuo, Jian" sort="Zhuo, Jian" uniqKey="Zhuo J" first="Jian" last="Zhuo">Jian Zhuo</name></author><author><name sortKey="Wei, Hai Bin" sort="Wei, Hai Bin" uniqKey="Wei H" first="Hai-Bin" last="Wei">Hai-Bin Wei</name></author><author><name sortKey="Zhang, Fei" sort="Zhang, Fei" uniqKey="Zhang F" first="Fei" last="Zhang">Fei Zhang</name></author><author><name sortKey="Liu, Hai Tao" sort="Liu, Hai Tao" uniqKey="Liu H" first="Hai-Tao" last="Liu">Hai-Tao Liu</name></author><author><name sortKey="Zhao, Fu Jun" sort="Zhao, Fu Jun" uniqKey="Zhao F" first="Fu-Jun" last="Zhao">Fu-Jun Zhao</name></author><author><name sortKey="Han, Bang Min" sort="Han, Bang Min" uniqKey="Han B" first="Bang-Min" last="Han">Bang-Min Han</name></author><author><name sortKey="Sun, Xiao Wen" sort="Sun, Xiao Wen" uniqKey="Sun X" first="Xiao-Wen" last="Sun">Xiao-Wen Sun</name></author><author><name sortKey="Xia, Shu Jie" sort="Xia, Shu Jie" uniqKey="Xia S" first="Shu-Jie" last="Xia">Shu-Jie Xia</name><affiliation><nlm:affiliation>Department of Urology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26732107</idno><idno type="pmid">26732107</idno><idno type="wicri:Area/PubMed/Corpus">000028</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000028</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.</title><author><name sortKey="Zhuo, Jian" sort="Zhuo, Jian" uniqKey="Zhuo J" first="Jian" last="Zhuo">Jian Zhuo</name></author><author><name sortKey="Wei, Hai Bin" sort="Wei, Hai Bin" uniqKey="Wei H" first="Hai-Bin" last="Wei">Hai-Bin Wei</name></author><author><name sortKey="Zhang, Fei" sort="Zhang, Fei" uniqKey="Zhang F" first="Fei" last="Zhang">Fei Zhang</name></author><author><name sortKey="Liu, Hai Tao" sort="Liu, Hai Tao" uniqKey="Liu H" first="Hai-Tao" last="Liu">Hai-Tao Liu</name></author><author><name sortKey="Zhao, Fu Jun" sort="Zhao, Fu Jun" uniqKey="Zhao F" first="Fu-Jun" last="Zhao">Fu-Jun Zhao</name></author><author><name sortKey="Han, Bang Min" sort="Han, Bang Min" uniqKey="Han B" first="Bang-Min" last="Han">Bang-Min Han</name></author><author><name sortKey="Sun, Xiao Wen" sort="Sun, Xiao Wen" uniqKey="Sun X" first="Xiao-Wen" last="Sun">Xiao-Wen Sun</name></author><author><name sortKey="Xia, Shu Jie" sort="Xia, Shu Jie" uniqKey="Xia S" first="Shu-Jie" last="Xia">Shu-Jie Xia</name><affiliation><nlm:affiliation>Department of Urology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Asian journal of andrology</title><idno type="eISSN">1745-7262</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 2-μm thulium laser resection of the prostate-tangerine technique (TmLRP-TT) has been introduced as a minimally invasive treatment for benign prostatic hyperplasia (BPH). This study was undertaken to assess the clinical efficacy and safety of TmLRP-TT for the treatment of BPH patients with previously negative transrectal prostate biopsy. A prospective analysis of 51 patients with previously negative transrectal prostate biopsy who underwent surgical treatment using TmLRP-TT was performed from December 2011 to December 2013. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at 1 and 6 months. TmLRP-TT was successfully completed in all patients. Mean prostate volume, operative duration, and catheterization time were 93.3 ± 37.9 ml, 69.5 ± 39.5 min, and 6.5 ± 1.3 days, respectively. The mean International Prostate Symptom Score, quality of life score, maximum urinary flow rate, and post-void residual urine volume changed notably at 6-month follow-up (22.5 ± 6.9 vs 6.1 ± 3.2, 4.8 ± 1.3 vs 1.1 ± 0.9, 7.3 ± 4.5 vs 18.9 ± 7.1 ml s-1 , and 148.7 ± 168.7 vs 28.4 ± 17.9 ml). Two (3.9%) patients required blood transfusion perioperatively, while 3 (5.9%) patients experienced transient hematuria postoperatively, and 2 (3.9%) patients received 3 days recatheterization due to clot retention. TmLRP-TT is a safe and effective minimally invasive technique for patients with previously negative transrectal prostate biopsy during the 6-month follow-up. This promising technology may be a feasible surgical method for previously negative transrectal prostate biopsy in the future.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">26732107</PMID><DateCreated><Year>2016</Year><Month>1</Month><Day>6</Day></DateCreated><DateRevised><Year>2016</Year><Month>1</Month><Day>7</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-7262</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2016</Year><Month>Jan</Month><Day>5</Day></PubDate></JournalIssue><Title>Asian journal of andrology</Title><ISOAbbreviation>Asian J. Androl.</ISOAbbreviation></Journal><ArticleTitle>Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.</ArticleTitle><Pagination><MedlinePgn></MedlinePgn></Pagination><ELocationID EIdType="doi">10.4103/1008-682X.168790</ELocationID><Abstract><AbstractText NlmCategory="UNASSIGNED">The 2-μm thulium laser resection of the prostate-tangerine technique (TmLRP-TT) has been introduced as a minimally invasive treatment for benign prostatic hyperplasia (BPH). This study was undertaken to assess the clinical efficacy and safety of TmLRP-TT for the treatment of BPH patients with previously negative transrectal prostate biopsy. A prospective analysis of 51 patients with previously negative transrectal prostate biopsy who underwent surgical treatment using TmLRP-TT was performed from December 2011 to December 2013. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at 1 and 6 months. TmLRP-TT was successfully completed in all patients. Mean prostate volume, operative duration, and catheterization time were 93.3 ± 37.9 ml, 69.5 ± 39.5 min, and 6.5 ± 1.3 days, respectively. The mean International Prostate Symptom Score, quality of life score, maximum urinary flow rate, and post-void residual urine volume changed notably at 6-month follow-up (22.5 ± 6.9 vs 6.1 ± 3.2, 4.8 ± 1.3 vs 1.1 ± 0.9, 7.3 ± 4.5 vs 18.9 ± 7.1 ml s-1 , and 148.7 ± 168.7 vs 28.4 ± 17.9 ml). Two (3.9%) patients required blood transfusion perioperatively, while 3 (5.9%) patients experienced transient hematuria postoperatively, and 2 (3.9%) patients received 3 days recatheterization due to clot retention. TmLRP-TT is a safe and effective minimally invasive technique for patients with previously negative transrectal prostate biopsy during the 6-month follow-up. This promising technology may be a feasible surgical method for previously negative transrectal prostate biopsy in the future.</AbstractText></Abstract><AuthorList><Author><LastName>Zhuo</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author><LastName>Wei</LastName><ForeName>Hai-Bin</ForeName><Initials>HB</Initials></Author><Author><LastName>Zhang</LastName><ForeName>Fei</ForeName><Initials>F</Initials></Author><Author><LastName>Liu</LastName><ForeName>Hai-Tao</ForeName><Initials>HT</Initials></Author><Author><LastName>Zhao</LastName><ForeName>Fu-Jun</ForeName><Initials>FJ</Initials></Author><Author><LastName>Han</LastName><ForeName>Bang-Min</ForeName><Initials>BM</Initials></Author><Author><LastName>Sun</LastName><ForeName>Xiao-Wen</ForeName><Initials>XW</Initials></Author><Author><CollectiveName>Jun-Lu</CollectiveName></Author><Author><LastName>Xia</LastName><ForeName>Shu-Jie</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Urology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ENG</Language><PublicationTypeList><PublicationType UI="">JOURNAL ARTICLE</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>1</Month><Day>5</Day></ArticleDate></Article><MedlineJournalInfo><MedlineTA>Asian J Androl</MedlineTA><NlmUniqueID>100942132</NlmUniqueID><ISSNLinking>1008-682X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pii">168790</ArticleId><ArticleId IdType="pubmed">26732107</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000028 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000028 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26732107
|texte= Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26732107" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |